Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
05/2005
05/17/2005US6893419 Indwelling heat exchange catheter and method of using same
05/12/2005WO2005042727A2 Methods of organ regeneration
05/12/2005WO2005032488A3 2,4-dioxo-3-quinazolinylaryl sulfonylureas
05/12/2005WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
05/12/2005US20050101661 Cyclooxygenase inhibitors; musculoskeletal and cardiovascular disorders; antiinflammatory agents
05/12/2005US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/12/2005US20050101612 Use of indole-3-acetic acids in the treatment of asthma, copd and other diseases
05/12/2005US20050101563 Using cyclooxygenase inhbitor and fatty acid; analgesics; antiinflammatory agents; antiarthritic agents; vision defects; urogenital disorders; gastrointestinal disorders
05/12/2005US20050101532 Protamine fragment compositions and methods of use
05/12/2005US20050101531 Use of recombinant gelatin-like proteins as plasma expanders and compositions suitable for plasma substitution
05/12/2005US20050101529 Protein modification and maintenance molecules
05/12/2005US20050101524 Using arsenic oxide, or complex thereof; angiogenesis inhibitors; anticarcinogenic agents; neurodegenerative agents; antiischemic agents
05/12/2005US20050101522 Antihyperplastic agents; antitumor agents; side effect reduction
05/12/2005US20050100902 5-cyano-1h-indole derivatives as antagonist of the inerleukine-8 receptors
05/12/2005US20050100894 Novel mitogen activated kinase
05/12/2005US20050100615 controling metabolic acidosis due to burn injury, hemorrhagic shock, multiple organ failure, systemic inflammatory response syndrome (SIRS); administering sodium bicarbonate
05/12/2005CA2544125A1 Use of ephrins and related molecules to regulate cellular proliferation
05/12/2005CA2543745A1 Methods of organ regeneration
05/12/2005CA2543238A1 Compositions and dosage forms for enhanced absorption
05/12/2005CA2543185A1 Compositions and dosage forms for ehnanced absorption of iron
05/11/2005EP1529105A1 Methods to reprogram splice site selection in pre-messenger rnas
05/11/2005EP1529058A2 A non-selective cation channel in neural cells and methods for treating brain swelling
05/11/2005EP1529041A1 NOVEL PRODRUGS OF 1-METHYL-2(4-AMIDINOPHENYLAMINOMETHYL)-BENZIMIDAZOL-5-YL-CARBOXYLIC ACID-( i N /i -2-PYRIDIL- i N /i -2-HYDROXYCARBONYLETHYL)-AMIDE, PRODUCTION AND USE THEREOF AS MEDICAMENTS
05/11/2005EP1529037A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
05/11/2005EP1529035A1 Crystalline (r)-2-(4-amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1(pyrrolidinocarbonyl)-ethyl)-benzimidazole, and the use thereof as antithrombotic agents
05/11/2005EP1528923A1 N-((3-oxo-2,3-dihydro-1h-isoindol-1-yl)acetyl)guanidine derivatives as nhe1-inhibitors for the treatment of infarction and angina pectoris
05/11/2005EP1421064B1 Process for the preparation of 3-spiro'cyclohexam-1,3'-'3h!indolin-2'-one! derivatives
05/11/2005EP1417172A4 Process for the preparation of amorphous form of torsemide
05/11/2005EP1315480B1 "slow release" pharmaceutical compositions comprising lithium carbonate
05/11/2005EP0839196B1 Human ctla-8 and uses of ctla-8-related proteins
05/11/2005EP0730606B1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
05/11/2005CN1615160A A haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
05/11/2005CN1615149A Drug mobilizing pluripotent stem cells from tissue into peripheral blood
05/11/2005CN1615144A A composition for treating neurocerebrovascular disorders
05/11/2005CN1615137A Drug delivery systems for the prevention and treatment of vascular diseases comprising rapamycin and derivatives thereof
05/11/2005CN1613490A Oral liquid of cuttle bone and rubia root for anormal metrorrhagia
05/11/2005CN1613447A Sustained released enteric soluble medicines
05/11/2005CN1613444A Efferverscent tablets containing troxerutin and their preparation
05/11/2005CN1200932C Substituted phenylcyclohexane carboxylic acid amides that have an adenosine uptake inhibiting effect
05/11/2005CN1200742C System and compositions used in perfusion applications
05/10/2005US6891047 Process for the preparation of amorphous atorvastatin
05/10/2005US6890943 3-acylated pyridoxal derivatives used to treat vitamin B6 deficiency, cardiovascular diseases, melanoma and other related diseases
05/10/2005US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/10/2005US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
05/10/2005US6890914 Method of locking 1α-OH of vitamin D compounds in axial orientation
05/10/2005US6890457 Infrared radiation emitting ceramic powders comprising zirconium or radium and oxides of silicon, aluminum, iron, titanium, calcium, magnesium, potassium and sodium, used for joining wood, paper, leather, metals or plastics; radiotherapy
05/06/2005WO2005040214A1 Virally-safe factor viii with a low content of higher multimers
05/06/2005WO2005040137A1 Aminoalkyl-pyrazinones and -pyridones as thrombin inhibitors
05/06/2005WO2005039602A1 Pharmacologically functional water and use thereof
05/06/2005WO2005039559A1 Composition functioning to prevent or mitigate symptom or disease attributable to blood vessel aging
05/06/2005WO2004015096A8 Leech extracts for stents
05/06/2005WO2003018606A3 Casein derived peptides and uses thereof in therapy
05/06/2005CA2543630A1 Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase u is beneficial, novel anabaenopeptin derivatives and intermediates thereof
05/06/2005CA2543095A1 Virally-safe factor viii with a low content of higher multimers
05/06/2005CA2541868A1 Antibodies having a mutated amino acid residue at position 268 (ch2 region) in constant regions
05/05/2005US20050096377 Substituted sulfonamide-indoles
05/05/2005US20050096328 Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor xa
05/05/2005US20050096321 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates
05/05/2005US20050096320 potent inhibitors of cyclic guanosine 3',5'-monophosphate-metabolizing phosphodiesterases (cGMP-PDEs)/phosphodiesterase isoenzymes PDE-I, PDE-II, PDE-V; therapeutic, antiaggregatory, antithrombotic, antiproliferative, antivasospastic, vasodilatory, natriuretic and diuretic effects; erectile dysfunction
05/05/2005US20050096277 Methods of prevention and treatment using apolipoprotein analogues
05/05/2005US20050095293 Bioavailability of drug independent of gastric pH; core comprised of water soluble acid(s) of tartaric acid, fumaric acid, succinic acid, citric acid, malic acid, glutamic acid, and/or aspartic acid or salts; acid resistance; drug delivery
05/04/2005EP1528061A1 Heterocyclic derivatives which inhibit factor Xa
05/04/2005EP1527787A1 Immediate release tablet
05/04/2005EP1527169A2 Leech extracts for stents
05/04/2005EP1527100A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
05/04/2005EP1527063A1 The 9, 11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma
05/04/2005EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
05/04/2005EP1526895A2 Methods for treating carbonic anhydrase mediated disorders
05/04/2005EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia
05/04/2005EP1526853A1 Use of a papaverine-like vasodilator and pharmaceutical composition
05/04/2005EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
05/04/2005EP1240165B1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases
05/04/2005EP1185292B1 Use of interleukin-11 to treat hemorrhagic shock
05/04/2005EP1023067B1 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function
05/04/2005EP0781340B1 Vaccine against group A Streptococcal infection
05/04/2005CN1612877A Spiroazacyclic compounds as monoamine receptor modulators
05/04/2005CN1612865A Triazole derivatives as cyclooxygenase (COX) inhibitors
05/04/2005CN1612864A Novel alkansulfonamides as endothelin antagonists
05/04/2005CN1612852A Lipoxin A4 analogs
05/04/2005CN1612752A Aqueous sustained-release formulations of proteins
05/04/2005CN1612746A Use of HEPCIDIN as a regulator of iron homeostasis
05/04/2005CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence
05/04/2005CN1612741A Use of sulfated glycosaminoglycans for establishing effective labor in women
05/04/2005CN1612688A Anti-pathogenic composition useful in blood preservation
05/04/2005CN1611513A Process of high purity albumin production
05/04/2005CN1611254A American ginseng fruit, and its medicinal composition and pharmaceutical use
05/04/2005CN1611243A Gastrodia-pseudo-ginseng micro-powder composition
05/04/2005CN1611240A Fresh ginger soft capsule and its preparing method
05/04/2005CN1200003C Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same
05/04/2005CN1199992C Gene-recombinant anticoagulant protein
05/04/2005CN1199690C Thrombosis resisting composition
05/03/2005US6888007 Stable crystal structure; thrombin inhibitor
05/03/2005US6887996 Compounds and their use
05/03/2005US6887994 C-nitroso compounds and use thereof
05/03/2005US6887905 Treatment of depression or generalized anxiety disorder
05/03/2005US6887890 For therapy of thrombocytopenia
05/03/2005US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
05/03/2005US6887870 Useful as antianginal and cardioprotective agents; for therapy and prophylaxis of angina pectoris, cardiac dysfunction, myocardial necrosis, and arrhythmia
05/03/2005US6887848 Vascular endothelial growth factor variants
05/03/2005US6887501 Isolated from cocoa beans; solvent extraction; nitric oxide synthase/lipoxygenase/cyclooxygenase modulators
1 ... 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 ... 671